Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
GH · against 1,216 other Healthcare companies
Ranked #214 of 1,217 · scores higher than 82% of peers
Bars: peers in each 10-point band of the growth score122 peers with a growth score of 80–89, including GH · Click a bar to see the companies
Mainly thanks to its revenue growth and 3-year revenue growth, which are stronger than most Healthcare peers.
| Metric | GH | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | 42.7% | 6.1% | 89% | 33% | |
| Earnings per share growthHigher is better · 682 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 1,192 reported | 32.4% | 5.8% | 88% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 214 | 67.60T KRW (≈$48.7B) | 82 | 72 | |
| 214 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 7.1B CNY (≈$998M) |
| 82 |
| 56 |
| 214 | 5.3B TWD (≈$165M) | 82 | 69 |
| 214 | Unavailable | 82 | 49 |
| 214 | 23.5B USD | 82 | 27 |
| 214 | 6.2B USD | 82 | 44 |
| 214 | 6.0B USD | 82 | 30 |
| 214 | 23.8B USD | 82 | 84 |
| 214 | 4.4B USD | 82 | 66 |